Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1618099Generated: October 26, 2026

Potassium Hydroxide → Warfarin Potassium

https://huagongshe.com/reaction/1618099

Reaction equation

Participants

RoleNameHCIDCharge
ReactantPotassium HydroxideHCID 14797—
ReactantPotassium bis(trimethylsilyl)amideHCID 3251421—
ReactantPotassiumHCID 5462222—
ReactantPotassium diisopropylamideHCID 11073506—
ReactantWarfarinHCID 54678486—
SolventWaterHCID 962—
SolventPotassium CarbonateHCID 11430—
SolventPotassium Phosphate, TribasicHCID 62657—
ProductWarfarin PotassiumHCID 23706212—

Reaction Steps

Illustrative embodiments of the present invention provide a process for preparing APO-II comprising: i. mixing Warfarin acid in isopropanol thereby forming a Warfarin mixture; ii. adding to the Warfarin mixture a potassium base selected from either ii-i) KOH, K2CO3, KHCO3, K3PO4, KOH in water, K2CO3 in water, KHCO3 in water, K3PO4 in water, KOH in ROH, K2CO3 in ROH, KHCO3 in ROH, K3PO4 in ROH, and mixtures thereof, wherein R is selected from the group consisting of H and C1-C4 alkyl, or ii-ii) KOH, K2CO3, KHCO3, K3PO4, KH, KNH2, potassium bis(trimethylsilyl)amide, potassium diisopropylamide and mixtures thereof, thereby forming a potassium Warfarin mixture; iii. heating the potassium Warfarin mixture to a temperature in a range of from about 45° C. to about 80° C. thereby forming a first solution; iv. maintaining the first solution at a pH in a range of from about 7.0 to about 10.0 thereby forming a Warfarin potassium isopropanol solution; v. distilling the Warfarin potassium isopropanol solution thereby forming a concentrated Warfarin potassium isopropanol solution; vi. adding additional isopropanol to the concentrated Warfarin potassium isopropanol solution and distilling further to remove water thereby forming a distilled Warfarin potassium isopropanol solution; vii. distilling the distilled Warfarin potassium isopropanol solution to dryness or near-dryness thereby forming a Warfarin potassium residue; viii. dissolving the Warfarin potassium residue in ethyl acetate thereby forming a Warfarin potassium ethyl acetate solution; ix. stirring the Warfarin potassium ethyl acetate solution at a temperature in a range of from about 5° C. to about 50° C. until precipitation occurs thereby forming a precipitate; and x. isolating the precipitate thereby isolating APO-II.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08765976B2
Source datasetuspto-grants-2014_07
ORD IDord-b248ee5b1e9344699802cdcf23ccf4a0
Source noteuspto-grants-2014_07